Teva Pharmaceutical Industries Ltd (Ticker: TEVA) has introduced new options contracts for February 2026. Notably, a put contract at a $29.00 strike price has a current bid of $0.50, allowing investors to potentially purchase shares at an effective cost of $28.50, representing a 7% discount from the current trading price of $31.15.
Additionally, a call contract at the $31.50 strike price is available with a bid of $0.02. Should investors utilize this in a covered call strategy, they would see a total return of 1.19% if the stock is called away at expiration. The likelihood of the put contract expiring worthless is estimated at 67%, while the call contract has a 48% chance of expiration without being exercised.
Implied volatility is observed at 65% for the put option and 47% for the call option, with the actual trailing twelve-month volatility calculated at 45%.
